CLOV на дневном тф медвежий флаг выбило вверх, отрисовав более высокий лоу. Вы знаете, что надо дел

ESPR Взято с файнанс точка yahoo точка ком: "There is a real risk the acquisition may face resistance, due to the following factors. Key Factors Influencing Approval Analyst Disconnect: The consensus one-year price target for ESPR among seven analysts is $5.54, significantly higher than the $3.16 offer MarketBeat. Institutional investors often use these targets to argue that the board is "selling low" before the company reaches its full potential. Institutional Concentration: Large holders like BlackRock (6.87%), Wasatch Advisors (6.13%), and Vanguard (5.81%) hold significant voting power Yahoo Finance. If these major firms believe the company is undervalued, they could block the 3/4 majority often required for such deals. Legal Investigations: Firms like Halper Sadeh LLC and Ademi LLP are specifically investigating if the deal terms "limit superior competing offers" or primarily benefit company insiders rather than ordinary shareholders Because of these factors, I will be holding on to my ESPR shares. Resistance could lead to a bump up in the price per share of ESPR. ARCHIMED could be forced to increase its price per share offer to somewhere between $4.00 to $6.00" Короче, обычно нужно 75% "за" чтоб одобрили поглощение. если крупные фонды посчитают, что контора недооценена, то голосуют против. аналитики ожидают $5,54 на горизонте в 12 месяцев. так что даже если одобрят поглощение, то будут суды (которые длится годами).